CLINICAL RESEARCH e-ISSN 1643-3750 © Med Sci Monit, 2014; 20: 884-888 DOI: 10.12659/MSM.889771
Carotid artery intima-media thickness and erectile dysfunction in patients with metabolic syndrome
Received: 2013.09.11 Accepted: 2014.02.08 Published: 2014.05.29
Authors’ Contribution: Study Design A Data Collection B Analysis C Statistical Data Interpretation D Manuscript Preparation E Literature Search F Collection G Funds
D 1 B 1 C 2 E 3 F 1 C 4 G 1
Corresponding Author: Source of support:
Background:
Material/Methods:
Results:
Conclusions:
Keywords:
Full-text PDF:
Mustafa Unal Duygu Yazgan Aksoy Yusuf Aydın Mine Durusu Tanriover Dilek Berker Jale Karakaya Serdar Guler
1 Department of Endocrinology and Metabolism, Numune Research and Training Hospital, Ankara, Turkey 2 Department of Internal Medicine, Section of Endocrinology and Metabolism, Duzce University, Duzce, Turkey 3 Department of Internal Medicine, Section of General Internal Medicine, Hacettepe University, Ankara, Turkey 4 Department of Biostatistics, Hacettepe University, Ankara, Turkey
Mustafa Unal, e-mail: [email protected] Departmental sources
Metabolic syndrome (MS) has become a pandemic in Turkey, as is the case globally. Increase in carotid artery intima-media thickness (CIMT) and erectile dysfunction (ED) may be evident before the clinical signs of cardiovascular disease appear. We aimed to investigate the prevalence of increased CIMT and ED as markers of atherosclerotic disease in patients with MS. Thirty-two patients with MS and 29 healthy controls were included. Anthropometric and biochemical parameters, along with total testosterone (TT), high sensitive C-reactive protein (hs-CRP), were recorded. Carotid artery intima-media thickness was measured. Erectile dysfunction was assessed with International Index of Erectile Function. Patients with MS had higher BMI, fasting plasma glucose, post-prandial plasma glucose, insulin, HOMA-IR, total cholesterol, triglycerides, hs-CRP, and CIMT, whereas TT levels were lower (p
Carotid artery intima-media thickness and erectile dysfunction in patients with metabolic syndrome
Received: 2013.09.11 Accepted: 2014.02.08 Published: 2014.05.29
Authors’ Contribution: Study Design A Data Collection B Analysis C Statistical Data Interpretation D Manuscript Preparation E Literature Search F Collection G Funds
D 1 B 1 C 2 E 3 F 1 C 4 G 1
Corresponding Author: Source of support:
Background:
Material/Methods:
Results:
Conclusions:
Keywords:
Full-text PDF:
Mustafa Unal Duygu Yazgan Aksoy Yusuf Aydın Mine Durusu Tanriover Dilek Berker Jale Karakaya Serdar Guler
1 Department of Endocrinology and Metabolism, Numune Research and Training Hospital, Ankara, Turkey 2 Department of Internal Medicine, Section of Endocrinology and Metabolism, Duzce University, Duzce, Turkey 3 Department of Internal Medicine, Section of General Internal Medicine, Hacettepe University, Ankara, Turkey 4 Department of Biostatistics, Hacettepe University, Ankara, Turkey
Mustafa Unal, e-mail: [email protected] Departmental sources
Metabolic syndrome (MS) has become a pandemic in Turkey, as is the case globally. Increase in carotid artery intima-media thickness (CIMT) and erectile dysfunction (ED) may be evident before the clinical signs of cardiovascular disease appear. We aimed to investigate the prevalence of increased CIMT and ED as markers of atherosclerotic disease in patients with MS. Thirty-two patients with MS and 29 healthy controls were included. Anthropometric and biochemical parameters, along with total testosterone (TT), high sensitive C-reactive protein (hs-CRP), were recorded. Carotid artery intima-media thickness was measured. Erectile dysfunction was assessed with International Index of Erectile Function. Patients with MS had higher BMI, fasting plasma glucose, post-prandial plasma glucose, insulin, HOMA-IR, total cholesterol, triglycerides, hs-CRP, and CIMT, whereas TT levels were lower (p
